Publication:
The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients

Simple item page
dc.contributor.authorsBasaran, G.; Saglam, S.; Tansan, S.; Demirel, M.; Gokmen, E.; Aktan, S.; Goker, E.; Kaban, K. K.; Saip, P.; Demir, G.; Bavbek, S. E.; Mandel, N. M.; Tecimer, C.; Turhal, N. S.; Garipoglu, M.
dc.date.accessioned2022-03-10T17:50:50Z
dc.date.accessioned2026-01-11T17:23:12Z
dc.date.available2022-03-10T17:50:50Z
dc.date.issued2011
dc.identifier.doi10.1200/jco.2011.29.15_suppl.e11042
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/221403
dc.identifier.wosWOS:000208880303017
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleThe impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.issue15
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume29

Files

Collections

Araştırma Çıktıları